查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1717771

獸藥市場按產品類型、疾病類型、動物類型、劑型、給藥途徑和最終用戶分類－2025-2030 年全球預測

Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計獸藥市值在 2024 年將達到 195.6 億美元，2025 年將達到 205.6 億美元，到 2030 年將達到 266.3 億美元，複合年成長率為 5.27%。

主要市場統計數據
基準年2024年 195.6億美元
預計2025年 205.6億美元
預測年份 2030 266.3億美元
複合年成長率（%） 5.27%

牲畜醫療保健產業正處於一個關鍵的十字路口——一個充滿活力的環境中，創新、研究和技術正在融合，以重新定義治療通訊協定並提高生產力。近年來，在不斷變化的消費者需求、監管壓力和突破性科學進步的推動下，該行業發生了重大變化。本報告深入研究市場，提供將當前趨勢與可行見解結合的全面概況。

隨著全球人口的成長和對永續蛋白質來源的需求的增加，牲畜護理已成為製藥公司、獸醫專業人士和農業相關人員關注的重點。此次綜合分析的範圍包括回顧影響產品開發和應用的各種因素。我們探討科學創新與實際應用的交集，以建構既有資訊量又有前瞻性的綜合敘述。

除了提供詳細的市場概述之外，該報告還強調了該領域的變化。這些變化鼓勵採用更科學、數據主導的方法來識別成長機會、最佳化投資，並最終確保動物健康管理繼續隨著研究和技術的進步而發展。每個談話要點都有確鑿的數據支持，並基於現實世界的應用，以增強各級決策者的能力。

改變獸藥市場

近年來，由於技術整合、數據分析的加強以及對精準獸醫學的日益重視，獸醫學經歷了關鍵性的轉變。先進診斷工具和創新治療方法的引入重新定義了傳統方法，使獸醫專業人員能夠採取積極主動的方式減輕疾病爆發並最佳化牲畜生產力。

最近，數位技術促進了海量資料集的收集和分析，從而能夠改善疾病預測並最佳化藥物處方。一個顯著的變化是從傳統方法轉向考慮疾病預防和整個牛管理的更全面的方法。這種不斷發展的模式與全球加強糧食安全和永續農業實踐的努力一致。

此外，對法規結構的審查和不斷變化的市場動態正在推動行業參與者比以往更多地投資於研發。採用精準給藥和重組疫苗等尖端解決方案不僅可以改善治療效果，還可以降低抗藥性的風險。這些轉型轉變凸顯了創新策略和適應性經營模式的重要性，以確保該產業在不斷變化的市場環境中保持敏捷和回應能力。

對不斷發展的市場的關鍵細分洞察

透徹了解市場區隔可以為牲畜醫療保健提供多方面的視角。這些見解來自按產品類型、疾病類型、動物類型、配方、給藥途徑和最終用戶定義的關鍵部分。在產品類型方面，市場調查顯示，抗發炎藥物、抗生素、抗寄生蟲藥、飼料添加劑、荷爾蒙和疫苗是推動產業發展的因素。深入研究每個類別，抗生素將根據頭孢菌素、青黴素和四環黴素進行仔細檢查，而抗寄生蟲藥物則會根據外寄生蟲殺蟲劑和內寄生蟲殺蟲劑進行進一步分析。同樣，飼料添加劑分為益生元和益生菌，激素分為生長激素和生殖激素，疫苗分為去活化疫苗、減毒活病毒疫苗和次單位疫苗。

此外，根據疾病類型進行分類，檢驗感染疾病、代謝性疾病、營養缺乏症、寄生蟲病和生殖疾病。每個疾病類別都面臨著獨特的挑戰和發展機會，推動了治療方案的進一步創新。根據動物類型，對水產養殖、牛、山羊、家禽、綿羊和豬進行了分析，重點介紹了不同的畜牧業實踐如何影響產品需求和治療方法。

就劑型而言，它分為膠囊、凝膠、液體、粉末和錠劑；就給藥途徑而言，在吸入、注射、口服和外用方面觀察到類似的反射分餾。值得注意的是，對於注射劑，仔細檢查肌肉注射和靜脈注射；對於口服劑，區分液體和錠劑；對於局部給藥，分析乳膏和貼片。最後，基於最終用戶的細分重點關注畜牧農民、獸醫診所和獸醫院的需求。這種詳細的細分框架確保了細緻的視角，並使相關人員能夠精確、有策略地識別特定的市場利基和目標細分市場。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 加強政府監管和努力，確保動物福利並最大限度地減少疾病傳播
      • 畜牧養殖戶越來越意識到預防性保健措施的好處
      • 牲畜疾病蔓延導致動物用藥品投資增加
    • 限制因素
      • 有限的研究資金和創新正在減緩下一代牲畜藥物的開發
    • 機會
      • 擴大畜牧生產中抗生素替代品的使用以因應監管變化
      • 與生技公司合作開發針對新興牲畜疾病的突破性疫苗
    • 任務
      • 畜牧業的疾病風險與生物安全
  • 市場區隔分析
    • 產品類型：抗生素在預防和控制牲畜細菌感染的重要性日益增加
    • 最終用戶：獸醫院在實施牲畜精準醫療方面發揮越來越大的作用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章獸藥市場（依產品類型）

  • 抗發炎劑
  • 抗生素
    • 頭孢菌素類
    • 青黴素
    • 四環黴素
  • 抗寄生蟲藥
    • 殺外寄生蟲劑
    • 體內殺寄生蟲劑
  • 飼料添加劑
    • 益生元
    • 益生菌
  • 荷爾蒙
    • 生長激素
    • 生殖荷爾蒙
  • 疫苗
    • 去活化疫苗
    • 減毒活疫苗
    • 次單位疫苗

第7章獸藥市場（依疾病類型）

  • 感染疾病
  • 代謝紊亂
  • 營養缺乏
  • 寄生蟲病
  • 生殖障礙

第8章 獸藥市場（依動物類型）

  • 水產養殖
  • 牛
  • 山羊
  • 家禽
  • 羊
  • 豬

第9章獸藥市場（按劑型）

  • 膠囊
  • 凝膠
  • 液體
  • 粉末
  • 藥片

第10章 獸藥市場依管理途徑分類

  • 吸入
  • 注射
    • 肌肉注射
    • 靜脈
  • 口服
    • 液體
    • 藥片
  • 話題
    • 奶油
    • 修補

第 11 章 獸藥市場（依最終用戶）

  • 畜牧養殖戶
  • 獸醫診所
  • 獸醫診所

第 12 章：美洲獸藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太獸藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 14 章歐洲、中東和非洲獸藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories SA
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • HIPRA SA
  • Indian Immunologicals Ltd.
  • Koninklijke DSM NV
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-FE3E5C0AE72F

The Livestock Medicine Market was valued at USD 19.56 billion in 2024 and is projected to grow to USD 20.56 billion in 2025, with a CAGR of 5.27%, reaching USD 26.63 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 19.56 billion
Estimated Year [2025] USD 20.56 billion
Forecast Year [2030] USD 26.63 billion
CAGR (%) 5.27%

The livestock medicine sector stands at a critical juncture-a dynamic environment where innovation, research, and technology converge to redefine treatment protocols and enhance productivity. In recent years, the industry has experienced significant changes driven by evolving consumer demands, regulatory pressures, and breakthrough scientific advancements. This report delves deep into the market, providing an extensive overview that merges current trends with actionable insights.

As the global population rises and the need for sustainable protein sources grows, livestock care becomes a key focus for pharmaceutical companies, veterinary professionals, and agricultural stakeholders. The scope of this comprehensive analysis includes a review of various factors affecting product development and application. It explores the convergence of scientific innovation with practical field applications, establishing an integrated narrative that is both informative and forward-looking.

In addition to presenting a detailed market overview, the report also highlights the transformative shifts in the sector. These changes have fostered a more scientific and data-driven approach to identifying growth opportunities, optimizing investments, and ultimately ensuring animal health management continuously evolves in pace with advancements in research and technology. Every discussion point is backed by robust data and grounded in real-world applications to empower decision-makers at every level.

Transformative Shifts in the Livestock Medicine Landscape

In the recent past, the landscape of livestock medicine has witnessed pivotal transformations resulting from technological integration, enhanced data analytics, and an increasing emphasis on precision veterinary care. The incorporation of advanced diagnostic tools and innovative treatment modalities has redefined traditional approaches, enabling veterinary professionals to adopt a proactive stance in mitigating disease outbreaks and optimizing animal productivity.

Recently, digital technologies have facilitated the collection and analysis of vast datasets, resulting in improved disease forecasting and optimized drug formulations. A notable shift has been the transition from conventional methodologies to a more holistic approach that factors in disease prevention and overall herd management. This evolving paradigm aligns with the global drive toward enhancing food security and achieving sustainable agricultural practices.

Furthermore, reforms in regulatory frameworks and evolving market dynamics are steering industry players to invest in research and development like never before. The adoption of cutting-edge solutions such as precision dosing and genetically tailored vaccines has not only improved treatment efficacy but also reduced the risk of drug resistance. These transformative shifts underscore the importance of innovative strategies and adaptive business models, ensuring that the sector remains agile and responsive amid ever-changing market conditions.

Key Segmentation Insights in the Evolving Market

A thorough understanding of market segmentation provides a multidimensional view of the livestock medicine landscape. These insights emerge from key segments defined by product type, disease type, animal type, formulation, route of administration, and end users. From the product type perspective, market research reveals that anti-inflammatory agents, antibiotics, antiparasitic agents, feed additives, hormones, and vaccines drive the industry. Delving deeper into each category, antibiotics are scrutinized based on cephalosporins, penicillins, and tetracyclines while antiparasitic agents are further analyzed across ectoparasiticides and endoparasiticides. Similarly, feed additives are dissected into prebiotics and probiotics, hormones are reviewed through the lens of growth and reproductive hormones, and vaccines are categorized into inactivated, live attenuated, and subunit vaccines.

Moreover, the segmentation based on disease type examines infectious diseases, metabolic diseases, nutritional deficiency diseases, parasitic diseases, and reproductive diseases. Each disease category presents unique challenges and growth opportunities that propel further innovation in treatment solutions. When considering animal type, the analysis spans aquaculture, cattle, goats, poultry, sheep, and swine, emphasizing how varied animal husbandry practices influence product demand and therapeutic approaches.

The segmentation by formulation categorizes offerings into capsules, gels, liquids, powders, and tablets, with a similar reflective partitioning observed in route of administration that spans inhalation, injectable, oral, and topical modalities. Notably, the injectable form is scrutinized meticulously across intramuscular and intravenous delivery, and the oral category distinguishes between liquids and tablet formulations, while the topical route is analyzed through creams and patches. Lastly, the segmentation based on end users focuses on the needs of livestock farmers, veterinary clinics, and veterinary hospitals. This detailed segmentation framework ensures a granular view, enabling stakeholders to identify specific market niches and target segments with precision and strategic clarity.

Based on Product Type, market is studied across Anti-inflammatory Agents, Antibiotics, Antiparasitic Agents, Feed Additives, Hormones, and Vaccines. The Antibiotics is further studied across Cephalosporins, Penicillins, and Tetracyclines. The Antiparasitic Agents is further studied across Ectoparasiticides and Endoparasiticides. The Feed Additives is further studied across Prebiotics and Probiotics. The Hormones is further studied across Growth Hormones and Reproductive Hormones. The Vaccines is further studied across Inactivated Vaccines, Live Attenuated Vaccines, and Subunit Vaccines.

Based on Disease Type, market is studied across Infectious Diseases, Metabolic Diseases, Nutritional Deficiency Diseases, Parasitic Diseases, and Reproductive Diseases.

Based on Animal Type, market is studied across Aquaculture, Cattle, Goats, Poultry, Sheep, and Swine.

Based on Formulation, market is studied across Capsules, Gels, Liquids, Powders, and Tablets.

Based on Route of Administration, market is studied across Inhalation, Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Intravenous. The Oral is further studied across Liquids and Tablets. The Topical is further studied across Creams and Patches.

Based on End Users, market is studied across Livestock Farmers, Veterinary Clinics, and Veterinary Hospitals.

Key Regional Insights Across Major Global Markets

The geographical analysis of the livestock medicine market reveals a diverse and region-specific character that significantly influences market dynamics and strategic developments. Regions like the Americas have evolved into hubs characterized by advanced agricultural practices, robust regulatory frameworks, and a strong emphasis on modernization. The growth in this area is driven primarily by technological advancements and a highly competitive environment that encourages innovation and the adoption of new therapeutic solutions.

Turning the lens to the Europe, Middle East & Africa region, we observe a blend of mature markets with a progressive outlook in some areas and emerging growth opportunities in others. The interplay between stringent regulatory policies and region-specific health challenges creates a unique ecosystem in which stakeholders must constantly adapt to shifting market trends. Furthermore, evolving consumer awareness and mounting pressure for sustainable practices further contribute to reshaping the market landscape in these regions.

In the Asia-Pacific area, rapid economic growth, increasing investments in veterinary health, and a surge in demand for efficient, scalable therapeutic solutions have marked the region as a rising star in the global market. Innovation, supported by a surge in research initiatives and regional policy reforms, continues to tilt market trends in favor of integrated disease management strategies. This tri-regional analysis underscores the reality that successful market navigation requires an astute understanding of local dynamics combined with a global perspective on emerging challenges and opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Industry Landscape

Prominent players have been instrumental in driving the evolution of the livestock medicine market by leveraging their expertise in research and development and forging strategic partnerships across international borders. Leaders such as Anicon Labor GmbH by SAN Group GmbH and AniCura Group by Mars Petcare have carved out significant market positions through consistent investment in cutting-edge technologies and robust research initiatives. Companies like Biogenesis Bago SA, Boehringer Ingelheim International GmbH, and Calier Laboratories S.A. further accentuate the competitive dynamics through their comprehensive product portfolios and innovative treatment modalities.

In addition, enterprises that have long been recognized as industry stalwarts, including Ceva Sante Animale, Dechra Pharmaceuticals PLC, and Elanco Animal Health Inc., continue to set high benchmarks in terms of product efficacy and market penetration. Noteworthy mentions also include HESTER BIOSCIENCES LIMITED and HIPRA S.A., which have emerged as key players driving the next wave of innovation in veterinary medicine. Other distinguished companies such as Indian Immunologicals Ltd., Koninklijke DSM N.V., Merck KGaA, and Neogen Corporation have significantly influenced market trends with their in-depth research and diversified therapeutic offerings.

Organizations like Norbrook Laboratories Ltd., Parnell Pharmaceuticals Holdings Ltd., and Phibro Animal Health Corporation have optimized their market strategies by targeting specific segmentation areas and investing in disruptive technologies. Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc. also play a pivotal role in shaping market dynamics. Their collective efforts in improving drug formulations and expanding therapeutic categories are critical for addressing modern livestock health challenges effectively.

The report delves into recent significant developments in the Livestock Medicine Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group GmbH, AniCura Group by Mars Petcare, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Calier Laboratories S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, HIPRA S.A., Indian Immunologicals Ltd., Koninklijke DSM N.V., Merck KGaA, Neogen Corporation, Norbrook Laboratories Ltd., Parnell Pharmaceuticals Holdings Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are advised to adopt a strategic framework that can effectively address the evolving complexities of the livestock medicine market. Initially, it is crucial to invest in robust research and development initiatives. Adopting a proactive stance by integrating advanced diagnostic technologies and digital monitoring systems can significantly enhance treatment outcomes. Stakeholders should focus on developing precision therapies that cater to distinct needs across various product and disease types.

Secondly, diversification into specialized segments is essential. A deep understanding of segmentation based on product type, disease type, animal type, formulation, route of administration, and end users provides an opportunity to tailor innovative products precisely aligned with market demands. Focusing on specific niches while also leveraging data-driven insights can streamline resource allocation and bolster competitive advantage.

Additionally, regional expansion strategies need careful consideration. Prioritizing regions such as the Americas for technological enhancements, the Europe, Middle East & Africa region for balancing mature dynamics with emerging trends, and the Asia-Pacific for leveraging booming growth potential can ensure a diversified revenue stream. Collaborations and strategic partnerships with local entities can significantly enhance market penetration and adaptability to regional regulatory frameworks.

Finally, decision-makers should keep a close watch on regulatory changes and market dynamics. Continuous monitoring of global trends and technological breakthroughs will not only mitigate risks but also enable the early adoption of breakthrough treatments and methodologies. Proactive risk management, together with targeted investment in innovation, provides the best pathway to staying ahead in a rapidly changing landscape.

Conclusion: Embracing the Future of Livestock Medicine

The evolving landscape of livestock medicine presents both significant challenges and unparalleled opportunities. In summing up, it is evident that technological integration, comprehensive segmentation analysis, and strategic regional insights are key drivers of the industry's future. The concerted efforts of leading companies, innovative research, and evolving market dynamics have all contributed to reshaping the market into a more resilient and adaptable environment.

As stakeholders continue to navigate this intricate landscape, the emphasis on precision therapies, data-driven decision making, and targeted geographic expansion becomes increasingly critical. The journey forward calls for a balanced approach that combines rigorous scientific inquiry with pragmatic business strategies to foster sustainable growth and robust market performance.

In essence, the livestock medicine market is on the brink of a transformative era. By embracing innovative practices and remaining alert to emerging trends, industry leaders can build a strong competitive advantage and drive significant value for both their organizations and the broader agricultural community.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased government regulations and initiatives to ensure animal welfare and minimize disease spread
      • 5.1.1.2. Growing awareness among livestock farmers about the benefits of preventive healthcare measures
      • 5.1.1.3. Rising prevalence of livestock diseases boosting investments in veterinary pharmaceuticals
    • 5.1.2. Restraints
      • 5.1.2.1. Limited research funding and innovation slowing down the development of next-generation livestock drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of antibiotic alternatives in livestock production in response to regulatory changes
      • 5.1.3.2. Collaboration with biotech firms to innovate groundbreaking vaccines for emerging livestock diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Risks of disease outbreaks and biosecurity in the livestock industry
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type : Growing significance of antibiotics in preventing and managing bacterial infections among livestock populations
    • 5.2.2. End Users: Rising role of veterinary hospitals in the implementation of precision medicine for livestock
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Livestock Medicine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Anti-inflammatory Agents
  • 6.3. Antibiotics
    • 6.3.1. Cephalosporins
    • 6.3.2. Penicillins
    • 6.3.3. Tetracyclines
  • 6.4. Antiparasitic Agents
    • 6.4.1. Ectoparasiticides
    • 6.4.2. Endoparasiticides
  • 6.5. Feed Additives
    • 6.5.1. Prebiotics
    • 6.5.2. Probiotics
  • 6.6. Hormones
    • 6.6.1. Growth Hormones
    • 6.6.2. Reproductive Hormones
  • 6.7. Vaccines
    • 6.7.1. Inactivated Vaccines
    • 6.7.2. Live Attenuated Vaccines
    • 6.7.3. Subunit Vaccines

7. Livestock Medicine Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Infectious Diseases
  • 7.3. Metabolic Diseases
  • 7.4. Nutritional Deficiency Diseases
  • 7.5. Parasitic Diseases
  • 7.6. Reproductive Diseases

8. Livestock Medicine Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Aquaculture
  • 8.3. Cattle
  • 8.4. Goats
  • 8.5. Poultry
  • 8.6. Sheep
  • 8.7. Swine

9. Livestock Medicine Market, by Formulation

  • 9.1. Introduction
  • 9.2. Capsules
  • 9.3. Gels
  • 9.4. Liquids
  • 9.5. Powders
  • 9.6. Tablets

10. Livestock Medicine Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Inhalation
  • 10.3. Injectable
    • 10.3.1. Intramuscular
    • 10.3.2. Intravenous
  • 10.4. Oral
    • 10.4.1. Liquids
    • 10.4.2. Tablets
  • 10.5. Topical
    • 10.5.1. Creams
    • 10.5.2. Patches

11. Livestock Medicine Market, by End Users

  • 11.1. Introduction
  • 11.2. Livestock Farmers
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. Americas Livestock Medicine Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Livestock Medicine Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Livestock Medicine Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Phibro Animal Health Corporation completes acquisition of Zoetis' medicated feed additive product portfolio
    • 15.3.2. Fischer MV partners with BAV to launch advanced vaccines in India
    • 15.3.3. Virbac's strategic acquisition of Sasaeah strengthens its position in Japan's livestock vaccine market
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anicon Labor GmbH by SAN Group GmbH
  • 2. AniCura Group by Mars Petcare
  • 3. Biogenesis Bago SA
  • 4. Boehringer Ingelheim International GmbH
  • 5. Calier Laboratories S.A.
  • 6. Ceva Sante Animale
  • 7. Dechra Pharmaceuticals PLC
  • 8. Elanco Animal Health Inc.
  • 9. HESTER BIOSCIENCES LIMITED
  • 10. HIPRA S.A.
  • 11. Indian Immunologicals Ltd.
  • 12. Koninklijke DSM N.V.
  • 13. Merck KGaA
  • 14. Neogen Corporation
  • 15. Norbrook Laboratories Ltd.
  • 16. Parnell Pharmaceuticals Holdings Ltd.
  • 17. Phibro Animal Health Corporation
  • 18. Vetoquinol S.A.
  • 19. Vetpharma Animal Health S.L.
  • 20. Virbac SA
  • 21. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. LIVESTOCK MEDICINE MARKET MULTI-CURRENCY
  • FIGURE 2. LIVESTOCK MEDICINE MARKET MULTI-LANGUAGE
  • FIGURE 3. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 4. LIVESTOCK MEDICINE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY NUTRITIONAL DEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 187. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 188. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 197. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 199. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 201. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 202. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 203. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 211. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 213. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 214. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 215. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 216. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 217. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 225. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 227. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 228. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 229. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 230. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 231. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 239. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 241. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 242. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 243. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 244. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 245. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 248. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 256. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 258. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 262. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 269. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 270. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 271. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 272. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 273. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 276. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 278. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 295. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 297. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 298. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 299. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 300. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 301. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 304. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 305. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 306. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 307. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 308. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 309. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 311. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 312. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 313. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 314. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 315. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 318. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 320. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 321. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 322. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 323. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 325. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 326. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 327. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 328. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 329. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 332. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 333. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 334. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 335. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 336. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA LIVE